Add like
Add dislike
Add to saved papers

Long-term outcomes of Metacognitive Narrative Psychotherapy for people diagnosed with schizophrenia.

OBJECTIVES: This study investigated long-term outcomes of Metacognitive Narrative Psychotherapy. Previous studies have shown the approach to be effective in enhancing recovery and metacognition in people with a diagnosis of schizophrenia.

DESIGN: A 2-year longitudinal follow-up case study design.

METHODS: Eight people with a diagnosis of schizophrenia received an average of 52 sessions over 13-26 months. Follow-up interviews were conducted and self-report measures administered at approximately 2 years (22-30 months) post-completion of therapy.

RESULTS: The majority of participants demonstrated reliable improvement from pre-treatment to 2-year follow-up on one or more of the outcome measures with some variation in patterns of improvement.

CONCLUSIONS: This study provides the first evidence that therapeutic gains in recovery and metacognition during Metacognitive Narrative Psychotherapy for people with a diagnosis of schizophrenia can be maintained at 2-year follow-up. Larger, controlled trials are warranted to ascertain the most important factors contributing to the facilitation and maintenance of gains over time.

PRACTITIONER POINTS: Research demonstrates the value of longer-term psychotherapy for patients with more severe and longer-term difficulties resulting from psychotic spectrum disorders. Metacognitive Narrative Psychotherapy has been demonstrated to facilitate improvement in a proportion of patients who present with a diagnosis of schizophrenia. Components of Metacognitive Narrative Psychotherapy can be incorporated into a range of therapeutic approaches for the benefit of patients.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app